These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28822831)

  • 21. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
    Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
    Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
    Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
    J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.
    Padua D; Mahurkar-Joshi S; Law IK; Polytarchou C; Vu JP; Pisegna JR; Shih D; Iliopoulos D; Pothoulakis C
    Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G446-57. PubMed ID: 27492330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
    Sakuma H; Katayama A; Saito Y; Komaki H; Nakagawa E; Sugai K; Sasaki M
    Brain Dev; 2011 May; 33(5):442-4. PubMed ID: 20797828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
    Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma.
    Niu L; Jiang J; Yin Y; Hu B
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):989-996. PubMed ID: 32048308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artemisinin ameliorates the symptoms of experimental autoimmune myasthenia gravis by regulating the balance of TH1 cells, TH17 cells and Treg cells.
    Chen W; Li FF; Li C; Sui JK; Meng QF; Li XL; Li H; Li CH; Li YB
    J Biol Regul Homeost Agents; 2018; 32(5):1217-1223. PubMed ID: 30334416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
    Aricha R; Feferman T; Scott HS; Souroujon MC; Berrih-Aknin S; Fuchs S
    J Autoimmun; 2011 Feb; 36(1):16-24. PubMed ID: 21035305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
    Aruna BV; Ben-David H; Sela M; Mozes E
    Immunology; 2006 Jul; 118(3):413-24. PubMed ID: 16827902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
    Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
    J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells in multiple sclerosis and myasthenia gravis.
    Danikowski KM; Jayaraman S; Prabhakar BS
    J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis.
    Allman W; Qi H; Saini SS; Li J; Tuzun E; Christadoss P
    J Neuroimmunol; 2012 Aug; 249(1-2):1-7. PubMed ID: 22626443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis.
    Nishimura T; Inaba Y; Nakazawa Y; Omata T; Akasaka M; Shirai I; Ichikawa M
    Brain Dev; 2015 Sep; 37(8):808-16. PubMed ID: 25563663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
    Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
    J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
    Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of artesunate in experimental autoimmune myasthenia gravis by upregulated T regulatory cells and regulation of Th1/Th2 cytokines.
    Meng QF; Zhang XX; Zhang Z; Chen W; Li XL; Wang YJ; Li FF; Li YB
    Pharmazie; 2018 Sep; 73(9):526-532. PubMed ID: 30223936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.